BOCA RATON, Fla., May 15, 2019 /PRNewswire/ -- Sensus
Healthcare, Inc. (NASDAQ: SRTS), a medical device company
specializing in highly effective, non-invasive treatments for both
oncological and non-oncological conditions, announced today that
Joe Sardano, CEO of the Company,
will present a corporate overview at the 20th Annual B. Riley FBR
Investor Conference on Thursday, May
23 at 11:00 a.m. Pacific time.
The conference will be held May
22-23., 2019 at the Beverly Hilton Hotel in Beverly Hills, Calif.
Mr. Sardano's presentation will be webcast live and available
for replay in the Investor Relations section of the Company's
website at www.sensushealthcare.com.
About Sensus Healthcare
Sensus Healthcare, Inc. is a
medical device company specializing in highly effective,
non-invasive, minimally-invasive, and cost-effective treatments for
both oncological and non-oncological conditions. The Sculptura™
robotic radiation oncology system provides targeted intraoperative
triple-modulated radiotherapy (IORT) and Brachytherapy utilizing
our proprietary, state-of-the-art 3D Beam Sculpting™ to treat
patients undergoing cancer treatment during surgery, or at the
tumor site, with a single dose. Sensus also offers its proprietary
low-energy X-ray technology known as superficial radiation therapy
(SRT), which is the culmination of more than a decade of research
and development, to treat non-melanoma skin cancers and keloids
with its SRT-100™, SRT-100+™ and SRT-100 Vision™ systems. With its
portfolio of innovative medical device products, Sensus provides
revolutionary treatment options to enhance the quality of life of
patients around the world.
For more information,
visit https://www.sensushealthcare.com.
Investor Contact:
Kim Sutton
Golodetz
LHA Investor Relations
(212) 838-3777
kgolodetz@lhai.com
Media Contacts:
Caitlin
Kasunich / Brittany
Tibaldi
KCSA Strategic Communications
212-896-1241 / 347-487-6794
ckasunich@kcsa.com / btibaldi@kcsa.com
View original
content:http://www.prnewswire.com/news-releases/sensus-healthcare-to-present-at-the-20th-annual-b-riley-fbr-investor-conference-300850490.html
SOURCE Sensus Healthcare, Inc.